DYNAMICS OF ECHOCARDIOGRAPHIC PARAMETERS OF PULMONARY HYPERTENSION DURING BOSENTAN THERAPY IN PATIENTS UNDERGOING PROGRAM HEMODIALYSIS

DAMINOV Botir, ABDUVAKHITOVA Asal

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2026-yil

Annotatsiya

Associated pulmonary hypertension worsens the prognosis for patients undergoing scheduled hemodialysis. Endothelin receptor antagonists, including bosentan, are standard treatment for pulmonary arterial hypertension. Echocardiography (TTE) remains a key tool for screening and longitudinal monitoring of the right heart and estimating PH probability. In this cohort, the addition of bosentan to comprehensive therapy in maintenance hemodialysis patients with pulmonary hypertension was associated with a marked improvement in pulmonary hemodynamics and right- heart function, demonstrating clinical feasibility in carefully selected hemodialysis patients with regular safety monitoring.

Maqola ma’lumotlari
MualliflarDAMINOV Botir, ABDUVAKHITOVA Asal
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2026-01-13
Jild10
Son6
TilRus

Kalit so‘zlar

легочная гипертензия; хроническая болезнь почек; гемодиализ; бозентан; эхокардиография; TAPSE; sPAP; эндотелин-1, pulmonary hypertension; chronic kidney disease; hemodialysis; bosentan; echocardiography; TAPSE; sPAP; endothelin-1, o'pka gipertenziyasi; surunkali buyrak kasalligi; gemodializ; bosentan

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar